Form 4: Replimune Group Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christopher Sarchi, Chief Commercial Officer of Replimune Group, sold 2,218 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 16, 2024, Christopher Sarchi, the Chief Commercial Officer of Replimune Group, Inc., sold 2,218 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the partial vesting of his restricted stock units (RSUs).
- The shares were sold at a weighted average price of $6.47, with individual transactions ranging from $6.46 to $6.55 per share.
- Following the transaction, Sarchi still beneficially owns 92,252 shares of Replimune Group, Inc.
- The sale was conducted according to an irrevocable 'sell to cover' provision in the RSU award agreements, not as a discretionary sale.
Sentiment
Score: 5
Explanation: This is a neutral event related to tax obligations and RSU vesting, with no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of the stock sale transaction. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.